ASSESSING THE IMPLEMENTATION OF THE RECOMMENDATIONS ON SECONDARY CARDIOVASCULAR PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION (A PHARMACO-EPIDEMIOLOGIC STUDY) ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Y.Y., Vozzhaev A.V.Cardiovascular Therapy and Prevention. Том 8. 2009. С. 71-75
QUALITY OF AMBULATORY PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE AND ITS COMPLICATIONS AMONG TYPE 2 DIABETES MELLITUS PATIENTS ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Y.Y., Tsiruleva Y.Y.Cardiovascular Therapy and Prevention. Том 7. 2008. С. 9-14
STABLE ANGINA PECTORIS: POPULATION TRENDS, DIAGNOSTICS, SECONDARY PREVENTION, AND ANTIANGINAL THERAPY ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Yu.Yu., Doronkina M.K.Cardiovascular Therapy and Prevention. Том 5. 2006. С. 49-54
SECONDARY PREVENTION OF CORONARY HEART DISEASE IN MOSCOW POPULATION PATIENTS WITH MYOCARDIAL INFARCTION ArticleOganov R.G., Lepakhin V.K., Fitilev S.B., Levin A.M., Shkrebneva I.I., Titarova Yu.Yu., Gromakovsaya S.V.Cardiovascular Therapy and Prevention. Том 4. 2005. С. 53-60
TACT-EFFECT OF TRIMETAZIDINE IN PATIENTS WITH STABLE EFFORT ANGINA IN COMBINATION WITH EXISTING THERAPY ArticleLepakhin V.K., Fitilev S.B., Rumyantseva E.G., Zharovva E.A., Levin A.M.Сердце: журнал для практикующих врачей. Том 1. 2002. С. 204-207
ВЛИЯНИЕ ТРИМЕТАЗИДА (ПРЕДУКТАЛА) НА КАЧЕСТВО ЖИЗНИ БОЛЬНЫХ СТАРШЕ 65 ЛЕТ СО СТАБИЛЬНОЙ СТЕНОКАРДИЕЙ НАПРЯЖЕНИЯ ArticleФитилев С.Б., Лепахин В.К., Ivanova E.V., Сыркин А.Л., Левин А.М.Клиническая фармакология и терапия. Том 10. 2001. С. 59-61